Immunotherapy reduces lung and liver fibrosis in mice

Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. Researchers have now developed an immunotherapy that specifically targets the cause -- activated fibroblasts -- while leaving normal connective tissue cells unharmed. If this approach is also found to work in humans, it could lead to an effective treatment for fibrosis.

from Top Health News -- ScienceDaily https://ift.tt/4B7Esp8